Search For "dcgi"
Expert panel recommends restricted emergency use nod to Bharat Biotech's C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): An expert panel of Drugs Controller General of India (DCGI) has recommended granting restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine, also known as Covaxin, government sources told ANI on Saturday.
Read More
Urdu Bulletin: Expert panel grants emergency use authorisation for vaccine
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): Various editions of Urdu publications have carried the prominent news that the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA) with certain conditions to COVID-1
Read More
Panel recommends to DCGI to grant emergency use authorisation to Serum's C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 1 (ANI) In a major development related to the COVID vaccine, the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA)with certain conditions to COVID-19 vaccine being manufact
Read More
Covaxin to be available in the first quarter of next year, says Bharat Bio
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 9 (ANI): Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday.
Read More
DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficac
Updated : 5 years, 3 months ago IST
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
Read More
Six COVID vaccine candidates in different clinical trial stage in India, t
Updated : 5 years, 3 months ago IST
New Delhi [India], December 8 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said that there are six COVID-19 vaccine candidates in different clinical trial stages being developed by various manufacturers in India.
Read More
Bharat Biotech applies for emergency use authorisation for its COVID-19 va
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General of India (DCGI), officials said.
Read More
Serum Institute of India seeks emergency use authorisation for its COVID-1
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
Read More
Pfizer becomes first pharma company in India to seek emergency use nod for
Updated : 5 years, 3 months ago IST
New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country.
Read More
DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19 vaccine
Updated : 5 years, 4 months ago IST
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Read More
Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volunteers
Updated : 5 years, 4 months ago IST
Moscow [Russia], October 23 (ANI): The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday.
Read More
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biote
Updated : 5 years, 4 months ago IST
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Read More